Salvador Carlucci, former Head of Competitive Intelligence at Roche and Novartis and CoFounder at Atacana Group, discussed the impacts and future implications of COVID-19 on Big Pharma with a focus on digital initiatives
CoFounder and President
As the world continues to fight a global pandemic, Big Pharma has been uniquely impacted. From an increased focus towards digitization, to supply chain disruptions and new initiatives to identity treatments and vaccines, COVID-19 has presented both unique challenges and big opportunities to the healthcare industry.
Guest speaker Salvador Carlucci, CoFounder and Director of Competitive Readiness at Atacana Group, will discussed how Big Pharma is preparing itself for a post-COVID era by taking a look into how major companies are adjusting to the quickened pace of digitization.
Watch the replay to learn about: